← All trials
NCT05426148
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2020
- Primary completion
- Aug 1, 2020
- Completion date
- Apr 30, 2021
- First posted
- Jun 21, 2022
- Last posted
- Jun 29, 2022
- Enrollment
- 540
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.Lead sponsor
- Government of ChinaCollaborator
- Government of ChinaCollaborator
- Government of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.